The new patents are in addition to more than forty-five U.S. and international patents already owned by PTS, Inc. These patents span such technology areas as vertical flow HDL determination, room-temperature-stable triglycerides, structures and techniques for creating multi-analyte test strips, data collection and management from point-of-care testing devices, the detection of various cholesterol-related blood analytes, and other test strip-related detection technologies.
About Polymer Technology Systems, Inc. (PTS, Inc.) - Polymer Technology Systems, Inc. is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS, Inc. designs, manufactures, and markets products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America, and the Pacific Rim. PTS, Inc. products include the CardioChek PA point-of-care instrument which is marketed to the professional diagnostics industry, and the CardioChek cholesterol analyzer for consumer use. The company offers a variety of single and combination tests for lipids (cholesterols), Glucose, and Ketone, as well as the CardioChek Health Risk Assessment (HRA) software package. For more information, visit www.cardiochek.com.
All trademarks used or mentioned in this release are protected by law.
|SOURCE Polymer Technology Systems, Inc.|
Copyright©2012 PR Newswire.
All rights reserved